What Can Stem Cells Actually Do? Signalling, Repair, and Real Limits

If you have read that stem cells "regenerate your body" or "turn back the clock," you have met the marketing. The science is more specific — and, in its honest form, more interesting. This guide looks at what mesenchymal stem cells (MSCs) are really thought to do, why the modern answer is "mostly signal, not rebuild," and where the clinical evidence genuinely stands. If you want the basics first — the types of stem cells and where they come from — start with what are stem cells?

The old idea versus the newer understanding

The intuitive story is simple: injected stem cells travel to a damaged area, become new tissue, and physically replace what was lost. It is an appealing picture, and it is largely not how MSCs are now believed to work. The leading understanding is that they act mainly through paracrine signalling — releasing a mix of growth factors and tiny vesicles that send instructions to the cells around them — rather than by engrafting and turning into significant amounts of new tissue ¹.

This matters enormously for expectations. A signalling cell can help tilt an environment toward repair; it is far less likely to single-handedly rebuild a worn joint or reverse years of ageing.

What MSCs are actually thought to do

Within that signalling role, a few mechanisms are reasonably well described — mostly from laboratory and animal studies:

• Release a secretome. MSCs secrete growth factors and tiny membrane packets (extracellular vesicles, including exosomes) that carry instructions to nearby cells ². This "cell-free" signalling is now considered central to how they act.
• Calm inflammation and modulate the immune system. This is the best-supported area: MSCs can interact with immune cells and dampen overactive inflammation ¹, which is why their most genuine clinical promise has been in immune and inflammatory conditions rather than in "regrowing" body parts.
• Support the body's own repair, indirectly, by improving the local environment.
• Differentiate — but less than assumed. They can become a limited range of cell types in the right conditions, but direct replacement appears to be a minor part of the real-world story.

So does it work in patients?

This is where honesty has to win over enthusiasm. The mechanisms above are real; the clinical proof that injecting MSCs reliably helps a given condition is, for most uses, still limited. Even in the single most-studied application — knee osteoarthritis — a systematic review found only short-term improvement and judged the overall evidence limited ³. The areas with the most legitimate momentum are immune and inflammatory (a few cell therapies are approved for specific, narrow indications), not the broad "anti-ageing" and "joint regeneration" claims that dominate advertising. We lay out that gap between promise and proof in our overview of regenerative medicine.

The one stem-cell therapy that is established

It is worth being clear that proven stem-cell medicine does exist — it just is not the injectable kind advertised for joints and ageing. The bone-marrow (haematopoietic) stem-cell transplant used to treat blood cancers like leukaemia and lymphoma is a genuine, decades-old, life-saving stem-cell therapy. It works because those blood-forming stem cells do engraft and rebuild an entire blood and immune system — a very specific, well-understood job. That success is often borrowed to lend credibility to unrelated MSC injections, but the two are different cells doing different things. Real, established stem-cell therapy is narrow and specific; the broad "stem cells for everything" menu is where proof runs out.

Why "what they can do" gets oversold

The over-selling works precisely because the underlying science is genuine. "MSCs reduce inflammation and support repair in the lab" is true — and it is one short, misleading step from there to "stem cells heal arthritis, reverse ageing, and cure chronic disease." The honest position is that MSCs are a promising signalling tool whose real-world benefits are still being established, and that anyone presenting them as a proven cure for a broad list of conditions is ahead of the evidence.

What we see at the clinic

Most people who ask us about stem cells expect replacement — new cartilage, new tissue, a reset. The most useful thing we do is recalibrate that to signalling: explaining that the realistic hope is supporting the body's own processes in specific situations, not rebuilding from scratch. That honest framing usually lands well, and it makes any decision a sounder one.

Common questions

Do stem cells become new tissue when injected? Much less than the marketing implies. The leading view is that they mostly signal — supporting your own cells' repair — rather than becoming significant new tissue.

Can stem cells cure my arthritis? There is no good evidence they cure arthritis. Even the best-studied use (knee OA) shows only limited, short-term benefit, so "cure" overstates it considerably.

What's the most promising area? Immune and inflammatory conditions, where MSCs' ability to modulate the immune system has the strongest scientific footing — not broad anti-ageing claims.

Are exosomes doing the actual work? Exosomes are part of the signalling secretome MSCs release, which is why they are studied in their own right — see our guide to exosome therapy.

Does an IV of stem cells rejuvenate the whole body? There is no reliable evidence for whole-body "rejuvenation" from a stem-cell IV; that is one of the clearest examples of mechanism being stretched into marketing.

Key takeaway

Mesenchymal stem cells are best understood as signalling cells, not replacement parts: they release factors that can calm inflammation and support your body's own repair, with the strongest promise in immune and inflammatory conditions. The mechanisms are real, but the clinical proof is still limited for most uses — so judge any stem-cell offer against the evidence for your specific condition, and treat sweeping cure claims with scepticism. For the foundations, see what are stem cells?